Westerdykella reniformis sp. nov., producing the antibiotic metabolites melinacidin Iv and chetracin B

Westerdykella reniformis Ebead & Overy sp. nov. is described based on morphology and phylogenetic analyses using ITS, nLSU rDNA, and β-tubulin gene sequences. Westerdykella reniformis is characterized by the production of cleistothecioid ascomata, containing small globose to subglobose asci with...

Full description

Saved in:
Bibliographic Details
Main Authors: Ghada A Ebead, David P. Overy, Fabrice Berrué, Russell G. Kerr
Format: Article
Language:English
Published: BMC 2012-12-01
Series:IMA Fungus
Subjects:
Online Access:http://www.ingentaconnect.com/content/ima/imafung/2012/00000003/00000002/art00019
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Westerdykella reniformis Ebead & Overy sp. nov. is described based on morphology and phylogenetic analyses using ITS, nLSU rDNA, and β-tubulin gene sequences. Westerdykella reniformis is characterized by the production of cleistothecioid ascomata, containing small globose to subglobose asci with 32, aseptate, dark colored, pronouncedly reniform ascospores having a concave central groove. The isolate was obtained from a red alga (Polysiphonia sp.) collected from the tidal zone in Canada at low tide. Organic extracts enriched in extrolites, obtained from fermentation on a rice-based media, inhibited the growth of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VRE), S. warneri, and Proteus vulgaris. Presented here is the identification of the compounds responsible for the observed antimicrobial activity, the taxonomic description of W. reniformis, and a dichotomous key to the known species of Westerdykella based on macro- and micromorphological characters.
ISSN:2210-6340
2210-6359